Fosinopril Sodium And Hydrochlorothiazide
NDC Package 57237-026-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Fosinopril Sodium And Hydrochlorothiazide is a . Marketed by Rising Pharma Holdings, Inc., this product is identified by NDC 57237-026 and is authorized under FDA application ANDA079245.

Identification & Billing

NDC Package Code
57237-026-30
Package Description
30 TABLET in 1 BOTTLE
Product Code
57237-026
11-Digit Billing Format
57237002630
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA

Clinical Specifications

Proprietary Name
Fosinopril Sodium And Hydrochlorothiazide
Dosage Form
-

Regulatory & Marketing

Labeler Name
Rising Pharma Holdings, Inc.
FDA Application #
ANDA079245
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-09-2009
End Marketing Date
07-10-2009
Listing Expiration
07-10-2009
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (57237-026). Click a package code to view its specific billing and regulatory data.

57237-026-01
100 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 57237-026-30 identifies a specific commercial package of 30 tablet in 1 bottle of Fosinopril Sodium And Hydrochlorothiazide, labeled by Rising Pharma Holdings, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rising Pharma Holdings, Inc. on July 09, 2009. The current certification is valid through July 10, 2009.

How is this Rising Pharma Holdings, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 57237002630. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
57237-026-30
11-Digit CMS (5-4-2)
57237-0026-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.